PT1406895E - Formulações de lactonas e métodos para o seu uso - Google Patents
Formulações de lactonas e métodos para o seu uso Download PDFInfo
- Publication number
- PT1406895E PT1406895E PT02734779T PT02734779T PT1406895E PT 1406895 E PT1406895 E PT 1406895E PT 02734779 T PT02734779 T PT 02734779T PT 02734779 T PT02734779 T PT 02734779T PT 1406895 E PT1406895 E PT 1406895E
- Authority
- PT
- Portugal
- Prior art keywords
- lactone
- formulations
- lactone formulations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29787501P | 2001-06-13 | 2001-06-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1406895E true PT1406895E (pt) | 2008-11-04 |
Family
ID=23148076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT02734779T PT1406895E (pt) | 2001-06-13 | 2002-06-12 | Formulações de lactonas e métodos para o seu uso |
Country Status (21)
Country | Link |
---|---|
US (3) | US6900242B2 (pt) |
EP (1) | EP1406895B1 (pt) |
JP (1) | JP2005500289A (pt) |
KR (1) | KR20040030676A (pt) |
AR (1) | AR036056A1 (pt) |
AT (1) | ATE406367T1 (pt) |
AU (1) | AU2002306150B2 (pt) |
BR (1) | BR0210432A (pt) |
CA (1) | CA2450660C (pt) |
CO (1) | CO5550429A2 (pt) |
CY (1) | CY1108590T1 (pt) |
DE (1) | DE60228576D1 (pt) |
DK (1) | DK1406895T3 (pt) |
ES (1) | ES2315365T3 (pt) |
IL (3) | IL159296A0 (pt) |
MX (1) | MXPA03011554A (pt) |
PT (1) | PT1406895E (pt) |
RS (1) | RS52139B (pt) |
UY (1) | UY27334A1 (pt) |
WO (1) | WO2002100854A1 (pt) |
ZA (1) | ZA200400208B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2450660C (en) * | 2001-06-13 | 2011-08-16 | Magnachem International Laboratories, Inc. | Lactone formulations and method of use |
US8188145B2 (en) | 2002-06-12 | 2012-05-29 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations and method of use |
CN1720242A (zh) | 2002-11-05 | 2006-01-11 | 马格纳化学国际实验室公司 | 合成的内酯制剂及其使用方法 |
US20050045197A1 (en) * | 2003-08-28 | 2005-03-03 | Gelder Steven K. | Multiple drug delivery system & method |
JP2012507010A (ja) * | 2008-10-24 | 2012-03-22 | マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド | Rad9と選択的に相互作用する化合物をスクリーニングするための方法 |
CN103099901B (zh) * | 2013-01-26 | 2014-07-30 | 张红 | 一种治疗子宫内膜移位症的中药灌肠剂 |
KR101988479B1 (ko) * | 2017-10-11 | 2019-09-24 | (주)휴럼 | 리트세노라이드를 유효성분으로 하는 헬리코박터 파이로리 균주로부터 유래되는 위장질환 예방 및 치료용 약학 조성물 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2624723A (en) * | 1947-03-03 | 1953-01-06 | Allied Chem & Dye Corp | Lactone derivatives and method of making |
US2624732A (en) * | 1950-05-10 | 1953-01-06 | Burroughs Wellcome Co | Preparation of 5-benzyl-2,4-diaminopyrimidines |
US3203953A (en) * | 1963-01-18 | 1965-08-31 | Ciba Geigy Corp | Lactone obtained from helenium sp. and derivatives thereof |
US3210377A (en) * | 1963-06-05 | 1965-10-05 | Olin Mathieson | Gamma lactones |
US4001425A (en) * | 1974-04-17 | 1977-01-04 | E. I. Du Pont De Nemours And Company | Methods of treating hypertension and pharmaceutical compositions comprising 1-tertiary-alkyl-3-(substituted furyl)ureas as antihypertensive agents |
JPS5111173B2 (pt) * | 1974-04-25 | 1976-04-09 | ||
JPS51125722A (en) | 1975-01-13 | 1976-11-02 | Sumitomo Chem Co Ltd | Germicides for industry and their preparation |
JPS597713B2 (ja) | 1977-12-19 | 1984-02-20 | 三井東圧化学株式会社 | 新規γ↓−ブチロラクトン誘導体とその製造法 |
JPS56128776A (en) | 1980-03-14 | 1981-10-08 | Otsuka Pharmaceut Factory Inc | Alpha-methylene gamma-butyrolactone derivative |
JPS58199413A (ja) | 1982-05-13 | 1983-11-19 | Pioneer Electronic Corp | デイジタル変調信号の読取装置 |
JPS6058973A (ja) * | 1983-09-13 | 1985-04-05 | Mitsubishi Yuka Yakuhin Kk | γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤 |
JPS6226221A (ja) | 1985-07-29 | 1987-02-04 | Japan Tobacco Inc | 抗変異原性剤 |
JP2524760B2 (ja) | 1987-07-10 | 1996-08-14 | テイカ株式会社 | 新規抗生物質 |
JPH01163175A (ja) | 1987-12-21 | 1989-06-27 | Ss Pharmaceut Co Ltd | フラン−2−オン誘導体 |
US5242945A (en) * | 1991-04-12 | 1993-09-07 | American Home Products Corporation | Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors |
US5250735A (en) * | 1992-04-03 | 1993-10-05 | University Of Pittsburgh | 2-(N-substituted-aminoalkyl)-5-(E)-alkylidene cyclopentanones, 2-(N-substituted-aminoalkyl)-5-(E)-arylalkylidene cyclopentanones, and derivatives thereof |
EP0720607A1 (en) * | 1993-09-17 | 1996-07-10 | PHARMACIA & UPJOHN COMPANY | Substituted tetronic acids useful for treating hiv and other retroviruses |
US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
DE69522589T2 (de) * | 1994-06-07 | 2002-04-18 | Teijin Ltd | Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung |
AUPN191295A0 (en) | 1995-03-23 | 1995-04-27 | Unisearch Limited | Microbiocide or microbial regulator |
US5962460A (en) * | 1995-06-27 | 1999-10-05 | National Science Council (Taiwan) | Antineoplastic α-methylene-γ-butyrolactones |
US5646164A (en) * | 1995-11-14 | 1997-07-08 | National Science Council | α-methylene-γ-butyrolactones: new inhibitors of platelet aggregation |
DK0869784T3 (da) | 1995-11-17 | 2006-01-16 | Univ Johns Hopkins | Hæmning af fedtsyresyntase som middel til formindskelse af adipocytmængden |
US6222048B1 (en) * | 1995-12-18 | 2001-04-24 | Merck Frosst Canada & Co. | Diaryl-2-(5H)-furanones as Cox-2 inhibitors |
US5618835A (en) | 1996-02-01 | 1997-04-08 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
US6180651B1 (en) * | 1996-04-04 | 2001-01-30 | Bristol-Myers Squibb | Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
US5939455A (en) | 1997-03-11 | 1999-08-17 | Beacon Laboratories, Inc. | Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives |
JP2001518087A (ja) | 1997-04-02 | 2001-10-09 | メルク フロスト カナダ アンド カンパニー | 選択的シクロオキシゲナーゼ−2阻害薬としてのα−メチレン−γ−ラクトン類 |
US5905089A (en) * | 1997-04-14 | 1999-05-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Use of sesquiterpene lactones for treatment of severe inflammatory disorders |
AUPP303498A0 (en) | 1998-04-17 | 1998-05-14 | Unisearch Limited | Inhibition of gram positive bacteria |
AU4428899A (en) * | 1998-06-08 | 1999-12-30 | Advanced Medicine, Inc. | Multibinding inhibitors of cyclooxygenase-2 |
AU3889900A (en) * | 1999-03-30 | 2000-10-16 | E.I. Du Pont De Nemours And Company | Process for the preparation of alpha-methylene lactones |
FR2801792B1 (fr) | 1999-12-01 | 2003-04-18 | Sod Conseils Rech Applic | Un nouveau medicament, le dihydromikanolide, son obtention par extraction de la plante mikania micrantha et son utilisation comme agent anti-proliferatif |
US6660511B1 (en) | 2000-03-03 | 2003-12-09 | Rigel Pharmaceuticals, Inc. | Methods of screening for modulation of cell cycle |
AU2001258677A1 (en) * | 2000-05-22 | 2001-12-03 | Dr. Reddy's Research Foundation | Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them |
JP2002037797A (ja) * | 2000-07-25 | 2002-02-06 | Kanegafuchi Chem Ind Co Ltd | マクロファージ選択的細胞死誘導物質 |
CZ20031695A3 (en) | 2001-01-12 | 2004-03-17 | Société De Conseils De Recherches Et D'application | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
CA2450660C (en) * | 2001-06-13 | 2011-08-16 | Magnachem International Laboratories, Inc. | Lactone formulations and method of use |
US6686724B2 (en) * | 2002-05-21 | 2004-02-03 | Ford Motor Company | Method of and apparatus for controlling charging and/or discharging of a battery for a hybrid electric vehicle |
US8188145B2 (en) * | 2002-06-12 | 2012-05-29 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations and method of use |
CN1720242A (zh) * | 2002-11-05 | 2006-01-11 | 马格纳化学国际实验室公司 | 合成的内酯制剂及其使用方法 |
-
2002
- 2002-06-12 CA CA2450660A patent/CA2450660C/en not_active Expired - Fee Related
- 2002-06-12 EP EP02734779A patent/EP1406895B1/en not_active Expired - Lifetime
- 2002-06-12 PT PT02734779T patent/PT1406895E/pt unknown
- 2002-06-12 JP JP2003503621A patent/JP2005500289A/ja active Pending
- 2002-06-12 WO PCT/US2002/018602 patent/WO2002100854A1/en active Application Filing
- 2002-06-12 DK DK02734779T patent/DK1406895T3/da active
- 2002-06-12 DE DE60228576T patent/DE60228576D1/de not_active Expired - Lifetime
- 2002-06-12 BR BR0210432-6A patent/BR0210432A/pt not_active IP Right Cessation
- 2002-06-12 IL IL15929602A patent/IL159296A0/xx unknown
- 2002-06-12 MX MXPA03011554A patent/MXPA03011554A/es active IP Right Grant
- 2002-06-12 US US10/172,462 patent/US6900242B2/en not_active Expired - Lifetime
- 2002-06-12 AT AT02734779T patent/ATE406367T1/de active
- 2002-06-12 KR KR10-2003-7016356A patent/KR20040030676A/ko active Search and Examination
- 2002-06-12 ES ES02734779T patent/ES2315365T3/es not_active Expired - Lifetime
- 2002-06-12 RS YU98603A patent/RS52139B/en unknown
- 2002-06-12 AU AU2002306150A patent/AU2002306150B2/en not_active Ceased
- 2002-06-13 UY UY27334A patent/UY27334A1/es not_active Application Discontinuation
- 2002-06-13 AR ARP020102236A patent/AR036056A1/es not_active Application Discontinuation
-
2003
- 2003-12-10 IL IL159296A patent/IL159296A/en not_active IP Right Cessation
-
2004
- 2004-01-09 CO CO04001331A patent/CO5550429A2/es not_active Application Discontinuation
- 2004-01-12 ZA ZA2004/00208A patent/ZA200400208B/en unknown
-
2005
- 2005-05-26 US US11/139,338 patent/US20050209316A1/en not_active Abandoned
-
2008
- 2008-11-24 CY CY20081101353T patent/CY1108590T1/el unknown
-
2010
- 2010-12-15 US US12/968,508 patent/US8536348B2/en not_active Expired - Fee Related
-
2011
- 2011-03-27 IL IL211958A patent/IL211958A0/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2450660C (en) | 2011-08-16 |
US20110092588A1 (en) | 2011-04-21 |
EP1406895B1 (en) | 2008-08-27 |
UY27334A1 (es) | 2003-02-28 |
IL159296A0 (en) | 2004-06-01 |
CA2450660A1 (en) | 2002-12-19 |
BR0210432A (pt) | 2004-08-03 |
ES2315365T3 (es) | 2009-04-01 |
CY1108590T1 (el) | 2014-04-09 |
CO5550429A2 (es) | 2005-08-31 |
EP1406895A1 (en) | 2004-04-14 |
AU2002306150B2 (en) | 2008-02-14 |
DK1406895T3 (da) | 2008-12-01 |
US20030069393A1 (en) | 2003-04-10 |
KR20040030676A (ko) | 2004-04-09 |
RS98603A (en) | 2006-12-15 |
IL159296A (en) | 2011-06-30 |
US20050209316A1 (en) | 2005-09-22 |
WO2002100854A1 (en) | 2002-12-19 |
ZA200400208B (en) | 2005-06-29 |
ATE406367T1 (de) | 2008-09-15 |
EP1406895A4 (en) | 2004-11-17 |
US8536348B2 (en) | 2013-09-17 |
RS52139B (en) | 2012-08-31 |
IL211958A0 (en) | 2011-06-30 |
US6900242B2 (en) | 2005-05-31 |
JP2005500289A (ja) | 2005-01-06 |
DE60228576D1 (de) | 2008-10-09 |
AR036056A1 (es) | 2004-08-04 |
MXPA03011554A (es) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1420825A4 (en) | IMMUNOMODULAR COMPOUNDS AND USES THEREFOR | |
HUP0303732A2 (en) | Hsa-free formulations of interferon-beta | |
AU2002230831A1 (en) | Compositions of human proteins and method of use thereof | |
PL348343A1 (en) | Method of obtaining prolonged-release microparticles and prolonged-release microparticles as such | |
AU2002314466A1 (en) | Withasol and methods of use | |
IL211958A0 (en) | Lactone formulations and method of use | |
AU2001281140A1 (en) | Anti-plasmodium compositions and methods of use | |
IL160835A0 (en) | Catheter and method of using same | |
AU2002335085A1 (en) | Angiopoietins and methods of use thereof | |
ZA200306573B (en) | A vaccine composition and method of using the same | |
HU0104832D0 (en) | Cosmetic composition and method | |
AU2002363938A8 (en) | Methods and use of motoneuronotropic factors | |
EP1263935A4 (en) | SCYTONEMINE AND METHODS OF USE | |
IL160794A0 (en) | An enantiomerically pure diarylmethylpiperazine and methods of using same | |
AU2003287546A8 (en) | Synthetic lactone formulations and method of use | |
GB0105472D0 (en) | Smoke composition and method of use thereof | |
EP1414427A4 (en) | KAVALACTONE COMPOSITIONS AND METHODS OF USE | |
GB2394359B (en) | Microelctronic device and method of its manufacture | |
AUPQ760400A0 (en) | Herbical formulations and methods of use thereof | |
EP1392460A4 (en) | AMINOSILANOL HYDROFLUORIDES AND THEIR USE | |
PL351128A1 (en) | Method of obtaining phenoglycine and derivatives thereof | |
AU2002235438A1 (en) | Exercise device and method of use | |
EP1362193A4 (en) | ANKLE AND METHOD OF USE | |
EP1435953A4 (en) | ANTI-VESICANS COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE | |
AU2002326718A1 (en) | Tramdorins and methods of using tramdorins |